CoChat

Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities

Open access
Pistollato, Francesca, Ohayon, Elan L., Lam, Ann, Langley, Gillian R., Novak, Thomas J., Pamies, David, Perry, George, Trushina, Eugenia, Williams, Robin S.B., Roher, Alex E., Hartung, Thomas, Harnad, Stevan, Barnard, Neal, Morris, Martha Clare, Lai, Mei-Chun, Merkley, Ryan, Chandrasekera, P. Charukeshi · 2016 · Oncotarget
Cited by 77

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

// Francesca Pistollato 1 , Elan L. Ohayon 2 , Ann Lam 1,2 , Gillian R. Langley 3 , Thomas J. Novak 4 , David Pamies 5 , George Perry 6 , Eugenia Trushina 7 , Robin S.B. Williams 8 , Alex E. Roher 9,10 , Thomas Hartung 5 , Stevan Harnad 11 , Neal Barnard 1 , Martha Clare Morris 12 , Mei-Chun Lai 1 , Ryan Merkley 1 and P. Charukeshi Chandrasekera 1 1 Physicians Committee for Responsible Medicine, Washington, DC, USA 2 Green Neuroscience Laboratory, Neurolinx Research Institute, San Diego, CA, USA 3 Research and Toxicology Department, Humane Society International, London, UK 4 Cellular Dynamics International, Madison, WI, USA 5 CAAT, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA 6 College of Sciences, University of Texas at San Antonio, San Antonio, TX, USA 7 Department of Neurology, Mayo Clinic, Rochester, MN, USA 8 Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway University of London, Egham, UK 9 Division of Clinical Education, Midwestern University, Glendale, AZ, USA 10 Division of Neurobiology, Barrow Neurological Institute, Phoenix, AZ, USA 11 Department of Psychology, University of Quebec/Montreal, Montreal, Canada 12 Section of Nutrition and Nutritional Epidemiology, Department of Internal Medicine, Rush University, Chicago, IL, USA Correspondence to: Francesca Pistollato, email: // Keywords : Alzheimer disease, animal models, human methods, induced pluripotent stem cells, computational models, Gerotarget Received : September 29, 2015 Accepted : April 18, 2016 Published : May 04, 2016 Abstract Much of Alzheimer disease (AD) research has been traditionally based on the use of animals, which have been extensively applied in an effort to both improve our understanding of the pathophysiological mechanisms of the disease and to test novel therapeutic approaches. However, decades of such research have not effectively translated into substantial therapeutic success for human patients. Here we critically discuss these issues in order to determine how existing human-based methods can be applied to study AD pathology and develop novel therapeutics. These methods, which include patient-derived cells, computational analysis and models, together with large-scale epidemiological studies represent novel and exciting tools to enhance and forward AD research. In particular, these methods are helping advance AD research by contributing multifactorial and multidimensional perspectives, especially considering the crucial role played by lifestyle risk factors in the determination of AD risk. In addition to research techniques, we also consider related pitfalls and flaws in the current research funding system. Conversely, we identify encouraging new trends in research and government policy. In light of these new research directions, we provide recommendations regarding prioritization of research funding. The goal of this document is to stimulate scientific and public discussion on the need to explore new avenues in AD research, considering outcome and ethics as core principles to reliably judge traditional research efforts and eventually undertake new research strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.9175

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 77

Metadata

Authors
Pistollato, F., Ohayon, E. L., Lam, A., Langley, G. R., Novak, T. J., Pamies, D., Perry, G., Trushina, E., Williams, R. S. B., Roher, A. E., Hartung, T., Harnad, S., Barnard, N., Morris, M. C., Lai, M.-C., Merkley, R., & Chandrasekera, P. C.
Venue
Oncotarget
Published
2016-05-04
Volume
7
Issue
26
Pages
38999-39016
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2346245458
Cited by
77
References
29
FWCI
7.07
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities. https://app.cochat.ai/papers/10.18632/oncotarget.9175
The paper
Pistollato, F., Ohayon, E. L., Lam, A., Langley, G. R., Novak, T. J., Pamies, D., Perry, G., Trushina, E., Williams, R. S. B., Roher, A. E., Hartung, T., Harnad, S., Barnard, N., Morris, M. C., Lai, M.-C., Merkley, R., & Chandrasekera, P. C. (2016). Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities. Oncotarget. https://doi.org/10.18632/oncotarget.9175

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.